Suhagra Force 50mg/30mg Tablet for Erectile Dysfunction

Product Description

Suhagra Force 50 mg/30 mg Tablet is a combination pharmaceutical product containing sildenafil and dapoxetine as its active ingredients. According to the supplied product information, each tablet contains sildenafil 50 mg and dapoxetine 30 mg. The product is listed in a pack of four tablets, and Cipla Ltd is identified as the marketer in the source information. **Composition and Formulation** Sildenafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class, while dapoxetine belongs to the selective serotonin reuptake inhibitor (SSRI) class. The two ingredients have different pharmacological actions. The supplied listing identifies the dosage form as a tablet intended for oral administration. Additional formulation details, including inactive ingredients, tablet dimensions, colour and storage requirements, are not specified and should be verified against authentic product packaging. **Therapeutic Use** The supplied product information describes Suhagra Force as a medicine used in the management of erectile dysfunction and premature ejaculation in adult men. Sildenafil supports blood flow to penile tissue during sexual stimulation by inhibiting PDE5. Dapoxetine affects serotonin signalling and is used for premature ejaculation in certain markets, subject to local authorization and prescribing requirements. The inclusion of these two active ingredients does not establish that the specific combination product is approved in every country or suitable for every patient. Use should be based on an appropriate medical assessment and the prescribing instructions for an authorized product. **Packaging and Product Identification** The supplied listing specifies a four-tablet pack and identifies the product as Suhagra Force 50 mg/30 mg Tablet. Cipla Ltd is named as the marketer. The source does not separately confirm the manufacturing facility, country of origin, batch-specific expiry date, shelf life, packaging materials or complete ingredient list. These details should be confirmed through the original packaging and current manufacturer documentation before procurement. **Safety and Precautions** Sildenafil may interact with nitrate-containing medicines and cause a dangerous decrease in blood pressure. Dapoxetine can cause nausea, dizziness and fainting and may interact with certain antidepressants and other medicines. The combination requires professional assessment of potential interactions, contraindications and individual health conditions. People with cardiovascular disease, low blood pressure, a history of seizures, significant liver problems or relevant psychiatric conditions should discuss their medical history with a qualified healthcare professional before use. Commonly reported adverse effects include headache, nausea, dizziness and flushing. Patients should avoid driving if they experience dizziness, drowsiness or impaired concentration. Chest pain, sudden vision or hearing changes, or an erection lasting more than four hours requires urgent medical attention. **Procurement and Verification** Pharmaceutical distributors and eligible buyers should verify the active ingredients, individual strengths, pack configuration, marketer identity, batch number, expiry date and applicable regulatory documentation. The supplied information identifies Cipla Ltd as the marketer, but this attribution and the authenticity of any specific batch have not been independently verified. Confirm regulatory authorization in the intended market before publishing or procuring this product.

Additional Product Details

No additional product details available.

Product Specifications

Business Information